Israel Englander Altimmune, Inc. Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Altimmune, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,590,150 shares of ALT stock, worth $11.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,590,150
Previous 174,141
813.14%
Holding current value
$11.9 Million
Previous $1.96 Million
726.29%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ALT
# of Institutions
185Shares Held
44.4MCall Options Held
1.1MPut Options Held
647K-
State Street Corp Boston, MA8.65MShares$65 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.04MShares$30.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.13MShares$23.5 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$20.7 Million3.41% of portfolio
-
Morgan Stanley New York, NY2.21MShares$16.6 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $368M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...